Nextleaf Launches Highest Potency CBD Oil in Canada

Vancouver, British Columbia--(Newsfile Corp. - November 3, 2021) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a federally regulated producer of cannabis oil that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids, announced today the launch of Distilled CBD 100 Oil & Distilled CBD 200 Oil under the Company's prohibition-era brand Glacial Gold™.

Glacial Gold™ Distilled CBD 200 Oil is a first in Canada's adult-use and medical markets, with the highest amount of CBD in a single unit (5700 mg), highest potency of CBD available in an ingestible oil format (200 mg/g = 20 %), and best dollar value per milligram for CBD in both the legal and illicit markets in Canada.

Cannot view this image? Visit:

Glacial Gold Distilled CBD 100 Oil & Distilled CBD 200 Oil

To view an enhanced version of this graphic, please visit:

The Company's multi-patented winterization and filtration technology is the secret behind producing high-purity CBD distillate free of waxes, sugars, and other undesirable compounds.

A recent CBC Marketplace investigation report showed that the unregulated market for CBD is rife with misleading claims and contaminants that are harmful for consumers and would not meet standards within the regulated market[1].

"We are proud to be the first Company to launch a high-potency CBD product in Canada. By leveraging Nextleaf's competitive advantage producing high-purity distillate at scale, we are able to offer the lineup of Glacial Gold CBD products at disruptive price points," said Nextleaf CEO and co-founder Paul Pedersen. "When consumers purchase Glacial Gold products, they have a confidence that every millilitre is standardized for a predictable, safe, and repeatable outcome that simply cannot be guaranteed in products available from illicit sources, including unregulated CBD products produced in the United States".

Based on the early success of Glacial Gold™ Distilled CBD 50 Oil through retailers in British Columbia, Nextleaf is launching its new Glacial Gold™ Distilled CBD 100 & Distilled CBD 200 Oils. This expands the Glacial Gold lineup of Distilled CBD Oil offerings into a range of potencies for low, medium, and high dose CBD consumers. All Glacial Gold CBD Oil products are produced by Nextleaf using sun-grown hemp.

Glacial Gold™ CBD and THC products are currently sold across British Columbia, with plans to expand nationally next year.

Glacial Gold™ products are being made available to medical cannabis patients across Canada through

Glacial Gold™ 60 Day Review

Nextleaf launched its prohibition-era brand Glacial Gold™ in British Columbia, the Company's home province, in early September. After two months of sales, the brand continues to garner national attention for its quality distillate and accessible pricing from consumers, patients, and retailers, alike. Nextleaf continues to see increased demand within the province of British Columbia including higher volume purchase orders. A few key milestones and metrics over the September and October months:

  • Launched 7 SKUs of Glacial Gold™ THC and CBD products in B.C., consisting of four 1-gram vape SKUs and three distilled oil SKUs
  • The addition of Distilled CBD 100 & CBD 200 Oils amounts to 9 Glacial Gold™ SKUs listed in B.C. within the first 60 days of initial launch
  • 60%+ retail penetration rate with Glacial Gold™ in B.C.
  • Top value 1g vape cart in Canada (Anytime 1:1 Vape)
  • Top value CBD oil in Canada (Distilled CBD 50 Oil)
  • Signed an agreement with Quebec-based medical cannabis platform for distribution of Glacial Gold™ to medical cannabis patients across Canada
  • Signed agreement with National Cannabis Distribution Inc., a wholly-owned subsidiary of Kiaro Holdings Corp., for distribution of Glacial Gold™ in Saskatchewan

About Nextleaf®

Nextleaf is a federally regulated producer of cannabis oil that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids. Nextleaf distributes cannabis vapes and distilled oils under its award-winning prohibition-era brand, Glacial Gold™, and supplies cannabis distillate to its wholesale customers. Nextleaf's proprietary closed-loop automated extraction plant in Metro Vancouver efficiently transforms cannabis and hemp grown in B.C. and throughout Canada into high-purity cannabis distillate at an industrial scale. Nextleaf is developing delivery technology and differentiated cannabinoid-based formulations through its Health Canada Research Licence with sensory evaluation of cannabis via human testing. The Company owns 17 U.S. patents and has been issued 90 patents globally.

Nextleaf Solutions trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.

Follow the Company across social platforms: Twitter, LinkedIn, Facebook, and Instagram.

Follow Glacial Gold™ across social platforms: Instagram, Twitter, and Facebook. www.Glacial.Gold

For more information please contact:
Jason McBride, Corporate Development
604-283-2301 (ext. 219)

On behalf of the Board of Directors of the Company,
Paul Pedersen, CEO

Certain statements contained in this press release constitute "forward-looking statements". All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company's ability to capitalize on its IP portfolio, the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The CSE has not reviewed or approved the contents of this press release.


To view the source version of this press release, please visit